BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7841053)

  • 1. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
    Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
    Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
    Wu X; Zhang Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal breast cancer: analysis of proliferative activity using a monoclonal antibody to proliferating cell nuclear antigen (PCNA) and its relationship to histological grade and prognosis.
    Lanzafame S; Magro G; Broggi B
    Pathologica; 1994 Apr; 86(2):150-6. PubMed ID: 7936757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
    Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
    J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
    Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
    Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
    He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
    Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma].
    Schönborn I; Minguillon C; Reles A; Bartel U; Lichtenegger W
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):357-64. PubMed ID: 8964450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone.
    Oka K; Hoshi T; Arai T
    Cancer; 1992 Sep; 70(6):1545-50. PubMed ID: 1355399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of p185 product, p21 product, and proliferating cell nuclear antigen (PCNA) in formalin-fixed, paraffin-embedded tissues from ovarian carcinomas. Preliminary data.
    Gadducci A; Ciancia EM; Campani D; Malagnino G; De Luca F; Facchini V; Pingitore R; Fioretti P
    Eur J Gynaecol Oncol; 1994; 15(5):359-68. PubMed ID: 7828605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
    Mangham DC; Rowlands DC; Newbold KM; Reynolds GM; Fielding JW; Hallissey MT
    J Clin Pathol; 1994 May; 47(5):473-4. PubMed ID: 7913101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
    Gelb AB; Kamel OW; LeBrun DP; Warnke RA
    Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of proliferating cell nuclear antigen immunostaining in pediatric rhabdomyosarcomas.
    Tokuç G; Doğan O; Ayan I; Kebudi R; Doğan S; Demiryont M; Camlica H
    Acta Paediatr Jpn; 1998 Dec; 40(6):573-9. PubMed ID: 9893293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
    Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
    Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The manifestation of proliferating cell nuclear antigen in adenoid cystic carcinoma.
    Kim KH; Chung PS; Rhee CS; Kim WH
    Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1221-5. PubMed ID: 7917205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
    Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
    Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the PC10 index for patients with stage II and III oesophageal cancer treated with radiotherapy.
    Sugahara S; Ohara K; Takahashi A; Irie T; Watanabe T; Tanaka N; Nozawa K; Nakajima K; Itai Y
    Acta Oncol; 1999; 38(8):1057-62. PubMed ID: 10665763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.